Impact of the COVID-19 pandemic on lung transplant patients and on a cohort of patients with rare lung disease: A single-center study.

Fiche publication

Date publication

mars 2024

Journal

Respiratory medicine and research

Auteurs

Membres identifiés du Cancéropôle Est :
Pr FALCOZ Pierre-Emmanuel , Pr OLLAND Anne

Tous les auteurs :
Hussein M, Gallais F, Dégot T, Hirschi S, Leroux J, Riou M, Stauder J, Falcoz PE, Olland A, Kessler R, Renaud-Picard B

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/38657294

Résumé

Due to the COVID-19 pandemic, France underwent several lockdown periods during 2020. Our aim was to evaluate its clinical and social impact on lung transplant (LT) patients treated at Strasbourg University Hospital, by comparing three periods: first lockdown (T1: March-May 2020), end of the first lockdown (T2: May-October 2020), and second lockdown (T3: November-December 2020) and the incidence of COVID-19 infections. A cohort of patients with rare lung disease (RLD) was also studied during T2.